Operating Expenses Cambio Fecha
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Celltrion KRW 718.99B 24.68B 2025-06
Cspc Pharmaceutical CNY 5.22B 248.9M 2025-03
Dianthus Therapeutics USD 35.12M 1.88M 2025-06
Divis Laboratories Ltd 17.93B 130M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Kangmei Pharma CNY 1.25B 35.75M 2025-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 132.33M 179.02M 2025-06
MacroGenics USD 59M 23.06M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 19.8M 9.46M 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 72.9M 18.86M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Pharma Mar EUR 32.29M 9.66M 2025-06
Qiagen NV USD 397.57M 39.27M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 9.02B 702M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Sartorius EUR 722.5M 23.1M 2025-06
Sino Biopharmaceutical CNY 11.66B 352.34M 2024-12
Takeda JPY 922.12B 206.21B 2025-06
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.68B 272.39M 2025-06


Tectonic Therapeutic Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.